CLYRA TEAM
1.jpg)
Steve Harrison
Chief Executive Officer
Before joining Clyra, Mr. Harrison served on the Board of Directors of BioLargo, Inc. as Chairman of the Audit & Compensation committees and was an advisor for and investor in several healthcare and consumer products companies. Mr. Harrison was founder and CEO of InTouch Communications, Inc., a Competitive Local Exchange Carrier (CLEC), providing residential and business telephone services within the state of California. Mr. Harrison also served as CEO of Resource Medical Group, Inc., a provider of healthcare management consultancy services as well as President of Harrison Medical Technologies, Inc., a developer and marketer of diagnostic tests in partnership with University of California, Los Angeles.
Dennis Calvert
Chairman of the Board
Extensive management experience including CEO and Chairman of the Board for BioLargo Life Technologies, Inc. and chairman of the board of directors of Biolargo’s subsidiaries Odor- No-More, Inc., Clyra Medical Technologies, Inc. and BioLargo Water, Inc. (Canada).
Jack “Jay” Strommen
Director
CEO of PD Instore, a leader in the design, production and installation of retail environments for many Fortune 500 companies. Serves on the board of directors of several private and public companies.
Linda Park
​Director
Linda Park is a trusted executive and legal professional with a proven track record of supporting and advising public companies. With corporate board and executive experience at billion-dollar corporations such as her current roles working with Edward Lifesciences in her capacity as Corporate Secretary, Senior Vice President and Associate General Counsel, and Board Member of the Edwards Lifesciences Foundation, and prior work with Western Digital Corporation, Linda brings over 20 years of experience advancing organizations’ corporate governance and strategic goals. She also has many years of experience advising issuer and investment banking clients on corporate and securities matters, mergers and acquisitions, bank financings and capital markets, including initial public offerings. She is also an active partner and thought leader on environmental, social, and corporate governance issues. Linda has an undergraduate degree from Johns Hopkins University, and a law degree from Duke University School of Law.
Nick Valeriani
​
Director
Nick Valeriani recently retired as CEO of Gary and Mary West Health Institute, a nonprofit medical research organization that works to create new and more effective ways of delivering lower cost healthcare, a position he has held since 2012. Previously, Nicholas served for 34 years in key positions at Johnson & Johnson, including as company group chairman and on the executive committee. He received a bachelor’s degree in industrial engineering and a master of business administration from Rutgers University. Mr. Valeriani has served as a director and was most recently appointed Chairman of the Board of Edwards Lifesciences Corp.
Doug Morgan
​
Chief Operating Officer
Mr. Morgan is a senior technology executive, consultant and entrepreneur with more than 30 years of broad cross industry and public company board-level experience. He served as CEO of Performance Strategies, a business consulting firm assisting SMBs with business development, strategy, operations, market analysis, strategic partnerships and M&A. A seasoned public speaker and panelist, he also brings a strong IP background both creatively and analytically. Mr. Morgan holds over a dozen US patents, has served as an expert witness, and has managed IP strategy for numerous firms and driven IP litigation from both sides. He is a Summa Cum Laude graduate of both MIT (BS) in Computer Science and Stanford (MS) in EE and BioEngineering where he was a National Science Foundation Fellow and helped develop the algorithms for one of the first human implantable auditory prostheses.
.jpg)
Julian Bejarano
VP Product Development
& Innovation
Dr. Bejarano has over 13 years of experience in fundamental and applied research focused on materials science and engineering, particularly biomaterials for regenerative medicine and multifunctional nanoparticles for controlled drug delivery. Julian is a Materials Engineer and holds a Master degree in Materials Engineering from the Universidad del Valle, Colombia, and a Doctorate in Engineering Sciences with an emphasis in Materials Science from the University of Chile. Julian was a visiting researcher during his Ph.D. at the Institute of Biomaterials, University of Erlangen-Nuremberg, Germany. Following his doctorate program, Dr. Bejarano spent three years as a postdoctoral fellow at the Advanced Center for Chronic Diseases in Chile, working on the controlled release of active compounds from liposome-based nanosystems. Additionally, he was Research Advisor of the Group of Polymer Engineering at the Universidad de Chile working on projects related to bioactive and antimicrobials micro- and nanoparticles and biodegradable porous materials for bone regeneration. Dr. Bejarano has published a number of scientific papers in peer-reviewed journals about materials science and materials for medical applications. Also, he has presented his research work at international conferences on biomaterials and regenerative medicine.
Charles K. Dargan II
Chief Financial Officer
Charles K. Dargan II is the founder and President of CFO 911 Corporation, (www.cfo911.com) an organization of accounting, finance and operational experts who provide management and financial expertise to middle market private and small capitalization public companies to solve their critical accounting, finance and operational issues. CFO 911’s professionals have amassed a unique depth and breadth of operational and financial experience developed by having worked as CEOs, Presidents, COOs and CFOs of Fortune 500 firms, mid-cap and small-cap publicly traded companies, middle market and emerging growth private companies and not-for-profit organizations.  Mr. Dargan has also served as the Chief Financial Officer and Chief Operating Officer of both public and private companies in a wide variety of industries including software, technology, energy, retail, leisure, securities and business services. Mr. Dargan’s public company senior management experience includes Semotus Solutions, Inc., a wireless mobility software company, BioLargo, Inc. a disinfectant and sterilization company and CPSM, Inc., a pool service, resurfacing and refurbishing company. Mr. Dargan served as a director of CPSM, Inc., Hiplink Software and Anchor Audio, Inc. Further, Mr. Dargan began his finance career in investment banking with Drexel Burnham Lambert and later became Managing Director of two regional firms, including Houlihan Lokey Howard & Zukin, where he was responsible for the management of the private placement activities of the firm. Additionally, Mr. Dargan founded and was the Chief Financial Officer of Ambient Capital, a boutique investment bank and broker dealer. Mr. Dargan received his B.A. degree in Government from Dartmouth College, his M.B.A. degree and M.S.B.A. degree in Finance from the University of Southern California and holds a CPA and CFA license
Steven J. Kavros, DPM
Chief Medical Officer
Dr. Steven J. Kavros has been delivering focused, advance wound healing and limb preservation initiatives throughout his professional career. Patient care, education and research are the cornerstones in his career. After nine years in private practice, five years focused on business administration of orthopedic trauma and the reference laboratory medicine industry. Dr. Kavros excelled in a 20-year career at Mayo Clinic, Rochester, MN, then transitioned to the medical device industry focusing on regenerative medicine and its implications pertaining to advanced wound healing. As Associate Professor at the Mayo Clinic Alix School of Medicine, he has presented over 1,800 scientific presentations pertaining to his research at national and international conferences. Dr. Kavros is the primary author of numerous peer reviewed papers centered on new technology and evidence-based medicine in wound healing, vascular limb preservation, biomechanics, foot and ankle orthopedics and regenerative medicine. He has brought multiple medical devices to the market involving advanced wound healing, limb preservation, and orthopedics. Dr. Kavros received his bachelor’s degree in Biology with honors and a minor in Chemistry from Rutgers University. He graduated from Temple University School of Podiatric Medicine with highest honors in surgery, orthopedics, biomechanics, and podiatric medicine.
Dave Zansitis​
Senior Director
Markets & Business Development
Mr. Zansitis has an extensive clinical and healthcare industry background across multiple disciplines. Trained in Respiratory Care he worked in Critical Care and Burn Units in Philadelphia before transitioning to the distribution and marketing of Anesthesia and Respiratory devices and consumables. His career later shifted to sales of ophthalmic surgical implants and pharmaceuticals as a specialist with CooperVision and Pharmacia/Upjohn. His broad medical device experience further launched his career into the wound care arena where he successfully worked to launch the Wound Vac in the alternative care markets for KCI. He later went on to help develop Hypochlorous Acid wound irrigation solutions and gels at both PuriCore (Vashe) and Innovacyn (Puracyn) in Senior Market Manager and VP of Business Development positions. Today these wound care solutions have gained global clinical adoption in human and animal health.
Norman Fu
​
Director of Quality
Norman Fu brings over 30 years of quality and compliance experience, having held leadership positions across the medical device, pharma, diagnostic, and consumer goods industries at companies like Pfizer, Abbott, Medtronic, St. Jude Medical, and Becton Dickinson. He has helped establish and manage company quality systems to ensure compliance and global supplier quality. His approach to implementing simple, systematic, and sustainable quality systems has proved successful in multiple start-ups including Juul Labs, Green Thumb Industries, and FLUENT. Norman is an ASQ (American Society for Quality) Certified Quality Manager, Quality Engineer, and Quality Auditor. He is also an Exemplar Global Certified ISO13485 Medical Device Lead Auditor.
Catherine Matthieu
​Administrative Director
Catherine Matthieu brings more that 30 years of operational expertise and experience, with a focus on start-ups, strategic planning, operations, business development and M&A. She has lived and worked extensively in major Asian cities as well as the UK, Europe and the US. Catherine previously served as a Director of Oakwood Worldwide, where she was responsible for developing and implementing operating standards and procedures globally for this hospitality company and was centrally involved in both due diligence and financial modeling for a portfolio with over $1 billion in acquisitions.
Andrew L. Filler​​
Intellectual Property Strategy Advisor
Mr. Filler brings to Clyra over 20 years of experience in intellectual property for technology and medical device companies. He currently serves as Partner and General Counsel for Sherpa Technology Group since February 2014. In addition, Mr. Filler had served as General Counsel and Vice President of IP for Nanosys, Inc. since July 2004 and currently consults with the company on business and legal matters. Mr. Filler also served as chief intellectual property counsel at Caliper Technologies from January 2002 until June 2004, senior associate attorney at Weil, Gotshal & Manges from January 2000 until January 2002, and director of intellectual property at Corvascular from 1997 until 2000. We believe that Mr. Filler’s extensive experience as an intellectual property lawyer and managing extensive intellectual property portfolios make him a valuable member of our advisory team.
Jeffrey R. Marcus, MD FAAP FACS
​Associate Director of
Product Development
Dr. Jeffrey Marcus is Chief of Plastic, Maxillofacial, and Oral Surgery at Duke University. He is a past-President of the Rhinoplasty Society and the North Carolina Society of Plastic Surgeons. An internationally recognized expert in cleft lip and cleft palate, rhinoplasty, facial paralysis, and craniomaxillofacial surgery, he has authored over 100 publications in peer-reviewed journals. He is also the textbook editor of Essentials of Craniomaxillofacial Trauma, The Duke Cleft Video Atlas, and the Duke Flap Course Video Atlas. Dr. Marcus is actively engaged in surgical innovation and is the holder of several patents related to intermaxillary fixation that led to now sold worldwide that have substantively changed the practice of maxillofacial surgery. and abroad. Dr. Marcus has also developed innovations with market potential in the field of surgical irrigation and debridement.
Greg Lampert
Strategic Partnerships
Greg Lampert is the Founder and President of International Asset Group - a consultancy focused on business development and strategic partnering in a wide range of industries and service companies. Recent engagements have included assignments in health care devices - surgery lighting systems, gaming technology and app development, sober living communities, modular and student housing, etc. Mr. Lampert started his interest in the life sciences and health care from the establishment of a joint venture with the Biotechnology Organization (BIO - the industry trade group) and Technology Vision Group that resulted in a BioPartnering Asia conference held in Tokyo Japan in partnership with the Japan BioIndustry Association.  Since that time, he has worked with a number of health care related companies for business development and/or strategic partnering and fund raising. These firms included: XYLOS - a wound dressing company, E-med innovations - an internet connected stethoscope,  medicinal cannabis and several CBD products (pet food and coffee) as well as being an early investor in Clyra Medical Technologies.
Andrea Kochensparger
​Legal Advisor - Contracts
& Licensing
Andrea is a seasoned executive with international experience in a variety of leadership and legal roles in the life sciences industry, including General Counsel of Roxane Laboratories, and Division General Counsel, Head of Global Legal Operations for Zimmer Biomet. She is currently Fractional General Counsel for Tunnell Consulting, Inc., a life sciences consulting organization, and previously also served as VP and Deputy General Counsel for Akorn Operating Company where she handled M&A and supported all regulatory aspects and the company’s patent and trademark portfolio. Her technical experience cuts across a broad range of areas, including licensing, legal operations, project management, commercial transactions, M&A, ethics and compliance, regulatory affairs, litigation and risk management, labor and employment, and lobbying and government affairs.
Vanessa Lozano
​
Brand and Design Advisor
Mrs. Lozano is a Graphic & Visual Designer with more than 10 years of experience in design direction and brand development, working with a variety of clients from start-ups to multinational corporations.